< Back to previous page
Patent
Methylation status of gasdermin e gene as cancer biomarker
The present invention applies to the area of cancer diagnostics. In particular, the present invention is directed to a method for the ex vivo differential diagnosis between several cancer types in a subject based on the methylation status of the Gasdermin E (GSDME) gene. In a further aspect, the present invention relates to a method for the ex vivo differential diagnosis between several cancer types based on the methylation status of at least 2 CpG sites in the GSDME gene.
Patent Publication Number: WO2020178315
Year filing: 2020
Year approval: 2021
Year publication: 2020
Status: Requested
URI: link to Espacenet
Technology domains: Biotechnology
Validated for IOF-key: Yes
Attributed to: Associatie Universiteit & Hogescholen Antwerpen